Ani Pharmaceuticals (ANIP) Inventory Average (2013 - 2026)
Ani Pharmaceuticals (ANIP) posted Inventory Average of $143.3 million for Q1 2026, down 1.04% sequentially from $144.8 million in Q4 2025, and up 4.5% YoY from $137.1 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Inventory Average (2013 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Inventory Average for 14 years, with the latest figure at $143.3 million in Q1 2026.
- Quarterly Inventory Average rose 4.5% year-over-year to $143.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $143.3 million (up 4.5% YoY) and the FY2025 annual result came in at $139.9 million, up 12.85% from the prior year.
- Inventory Average retreated to $143.3 million in Q1 2026 per ANIP's latest filing, from $144.8 million in the prior quarter.
- Over five years, Inventory Average peaked at $144.8 million in Q4 2025 and troughed at $82.4 million in Q1 2022.
- A 5-year average of $118.9 million and a median of $112.5 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2025: Inventory Average soared 46.93% in 2022, then grew 1.66% in 2025.
- Over 5 years, Inventory Average stood at $105.3 million in 2022, then gained by 3.37% to $108.9 million in 2023, then surged by 30.78% to $142.4 million in 2024, then grew by 1.66% to $144.8 million in 2025, then slipped by 1.04% to $143.3 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $143.3 million, $144.8 million, and $142.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | 143.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 143.31 Mn |
| Mar 31, 2026 | 143.27 Mn |
| Dec 31, 2025 | 144.77 Mn |
| Sep 30, 2025 | 142.40 Mn |
| Jun 30, 2025 | 137.86 Mn |
| Mar 31, 2025 | 137.10 Mn |
| Dec 31, 2024 | 142.41 Mn |
| Sep 30, 2024 | 136.75 Mn |
| Jun 30, 2024 | 119.64 Mn |
| Mar 31, 2024 | 112.52 Mn |
| Dec 31, 2023 | 108.89 Mn |
| Sep 30, 2023 | 105.46 Mn |
| Jun 30, 2023 | 103.99 Mn |
| Mar 31, 2023 | 104.50 Mn |
| Dec 31, 2022 | 105.34 Mn |
| Sep 30, 2022 | 102.87 Mn |
| Jun 30, 2022 | 91.78 Mn |
| Mar 31, 2022 | 82.42 Mn |
| Dec 31, 2021 | 74.30 Mn |
| Sep 30, 2021 | 70.01 Mn |